OK Biotech (4155.TW) Earnings Analysis

OK Biotech (4155.TW) next reports earnings on 2026-08-07, consensus EPS 0.2572 TWD. Last quarter (2026-03-10) it beat with EPS 0.38 TWD vs 0.2572 TWD est (+47.7%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E 19.44.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does 4155.TW next report earnings?

Next earnings date2026-08-07
Consensus EPS estimate0.2572 TWD
Revenue estimate0.30B

4155.TW earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-100.38 TWD0.2572 TWD+47.7%Beat
2025-11-100.59 TWDn/an/an/a
2025-05-080.17 TWDn/an/an/a
2025-03-100.2724 TWDn/an/an/a
2024-08-090.28 TWDn/an/an/a

Beat rate: 1/1 (100%) over reported quarters with consensus data.

4155.TW valuation and analyst view

Trailing P/E19.44
Trailing EPS0.80076 TWD
Price / book0.87
Dividend yield1.93%
Market cap2.29B

Limited or no published sell-side analyst coverage for this symbol.

Related research pages

Frequently asked questions

When is OK Biotech (4155.TW)'s next earnings date?

OK Biotech is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 0.2572 TWD and revenue estimate of 0.30B.

Did 4155.TW beat earnings last quarter?

In its 2026-03-10 report, 4155.TW posted EPS of 0.38 TWD versus a 0.2572 TWD estimate — a beat of 47.7%.

What is 4155.TW's earnings track record?

Over the last 1 reported quarters with consensus data, 4155.TW beat estimates 1 times (100%).

What is 4155.TW's current P/E ratio and EPS?

4155.TW trades at a trailing P/E of 19.44 on trailing EPS of 0.8007638672373232 TWD.

What do analysts rate 4155.TW?

4155.TW has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.